![The apoB/apoA‐I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid‐lowering therapy – a review of the evidence - WALLDIUS - 2006 - Journal of Internal Medicine - The apoB/apoA‐I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid‐lowering therapy – a review of the evidence - WALLDIUS - 2006 - Journal of Internal Medicine -](https://onlinelibrary.wiley.com/cms/asset/78bd6665-5f2a-447a-a3a4-b811cabad8f2/joim_1643_f1.gif)
The apoB/apoA‐I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid‐lowering therapy – a review of the evidence - WALLDIUS - 2006 - Journal of Internal Medicine -
![Schematic presentation of ApoA-I peptide interaction with lipids. (A)... | Download Scientific Diagram Schematic presentation of ApoA-I peptide interaction with lipids. (A)... | Download Scientific Diagram](https://www.researchgate.net/publication/332757293/figure/fig1/AS:753375796793344@1556630195034/Schematic-presentation-of-ApoA-I-peptide-interaction-with-lipids-A-Synthetic-HDL.png)
Schematic presentation of ApoA-I peptide interaction with lipids. (A)... | Download Scientific Diagram
![Schematic representation of the actions of apolipoprotein A-I (apoA-I)... | Download Scientific Diagram Schematic representation of the actions of apolipoprotein A-I (apoA-I)... | Download Scientific Diagram](https://www.researchgate.net/publication/325588181/figure/fig1/AS:634346457268227@1528251389637/Schematic-representation-of-the-actions-of-apolipoprotein-A-I-apoA-I-and-high-density.png)
Schematic representation of the actions of apolipoprotein A-I (apoA-I)... | Download Scientific Diagram
![Biomolecules | Free Full-Text | The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer's Disease Biomolecules | Free Full-Text | The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer's Disease](https://www.mdpi.com/biomolecules/biomolecules-10-01276/article_deploy/html/images/biomolecules-10-01276-g001.png)
Biomolecules | Free Full-Text | The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer's Disease
![Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA- I Metabolism: A Systematic Overview Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA- I Metabolism: A Systematic Overview](https://static.hindawi.com/articles/jnme/volume-2017/5415921/figures/5415921.fig.001.jpg)
Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA- I Metabolism: A Systematic Overview
![High‐density lipoprotein‐related cholesterol metabolism in Alzheimer's disease - Pedrini - 2021 - Journal of Neurochemistry - Wiley Online Library High‐density lipoprotein‐related cholesterol metabolism in Alzheimer's disease - Pedrini - 2021 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1389501d-9d22-4313-bd6e-a9dca5c69240/jnc15170-fig-0005-m.jpg)
High‐density lipoprotein‐related cholesterol metabolism in Alzheimer's disease - Pedrini - 2021 - Journal of Neurochemistry - Wiley Online Library
![The Interaction of ApoA-I and ABCA1 Triggers Signal Transduction Pathways to Mediate Efflux of Cellular Lipids | Molecular Medicine | Full Text The Interaction of ApoA-I and ABCA1 Triggers Signal Transduction Pathways to Mediate Efflux of Cellular Lipids | Molecular Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.2119%2Fmolmed.2011.00183/MediaObjects/10020_2012_1802149_Fig1.jpg)
The Interaction of ApoA-I and ABCA1 Triggers Signal Transduction Pathways to Mediate Efflux of Cellular Lipids | Molecular Medicine | Full Text
![The Interaction of ApoA-I and ABCA1 Triggers Signal Transduction Pathways to Mediate Efflux of Cellular Lipids | Molecular Medicine | Full Text The Interaction of ApoA-I and ABCA1 Triggers Signal Transduction Pathways to Mediate Efflux of Cellular Lipids | Molecular Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.2119%2Fmolmed.2011.00183/MediaObjects/10020_2012_1802149_Fig2.jpg)
The Interaction of ApoA-I and ABCA1 Triggers Signal Transduction Pathways to Mediate Efflux of Cellular Lipids | Molecular Medicine | Full Text
![Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring Cholesterol Esterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo | Journal of Pharmacology and Experimental Therapeutics Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring Cholesterol Esterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/340/3/716/F1.large.jpg)
Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring Cholesterol Esterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo | Journal of Pharmacology and Experimental Therapeutics
![Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring Cholesterol Esterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo | Journal of Pharmacology and Experimental Therapeutics Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring Cholesterol Esterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/340/3/716/F8.large.jpg)
Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring Cholesterol Esterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo | Journal of Pharmacology and Experimental Therapeutics
![ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future | SpringerLink ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11883-022-01025-7/MediaObjects/11883_2022_1025_Fig1_HTML.png)
ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future | SpringerLink
![HDL (High-Density Lipoprotein) and ApoA-1 (Apolipoprotein A-1) Potentially Modulate Pancreatic α-Cell Glucagon Secretion | Arteriosclerosis, Thrombosis, and Vascular Biology HDL (High-Density Lipoprotein) and ApoA-1 (Apolipoprotein A-1) Potentially Modulate Pancreatic α-Cell Glucagon Secretion | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/e5b4719b-4ea9-4f4d-ad54-337ba00661f2/atvbaha.120.314640.fig11.jpg)
HDL (High-Density Lipoprotein) and ApoA-1 (Apolipoprotein A-1) Potentially Modulate Pancreatic α-Cell Glucagon Secretion | Arteriosclerosis, Thrombosis, and Vascular Biology
![Bovine apolipoprotein (apo)A-I displays more enhanced antioxidant and anti-atherosclerotic activity in lipid-free and lipid-bound states than human and porcine apoA-I Bovine apolipoprotein (apo)A-I displays more enhanced antioxidant and anti-atherosclerotic activity in lipid-free and lipid-bound states than human and porcine apoA-I](https://www.spandidos-publications.com/article_images/ijmm/32/4/IJMM-32-04-0843-g01.jpg)
Bovine apolipoprotein (apo)A-I displays more enhanced antioxidant and anti-atherosclerotic activity in lipid-free and lipid-bound states than human and porcine apoA-I
![Apolipoprotein A I/APOA1 siRNA (h), shRNA and Lentiviral Particle Gene Silencers | SCBT - Santa Cruz Biotechnology Apolipoprotein A I/APOA1 siRNA (h), shRNA and Lentiviral Particle Gene Silencers | SCBT - Santa Cruz Biotechnology](https://media.scbt.com/product/apoa-i-sirna-h-shrna-and-lentiviral-particle-gene-silencers-_36_17_g_361746.jpg)
Apolipoprotein A I/APOA1 siRNA (h), shRNA and Lentiviral Particle Gene Silencers | SCBT - Santa Cruz Biotechnology
Thomas Dayspring on Twitter: "CLICK: Apolipoprotein A-I produced in hepatocytes (most secreted, but some affixed to VLDL) or enterocytes (where most affixes to chylomicrons) lipidates (with PL or FREE cholesterol) and begins
![Molecular basis for a novel systemic form of human hereditary apoA-I amyloidosis with vision loss | bioRxiv Molecular basis for a novel systemic form of human hereditary apoA-I amyloidosis with vision loss | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2018/06/22/354001/F4.large.jpg)